Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 06  •  04:00PM ET
193.88
Dollar change
+36.84
Percentage change
23.46
%
May 06, 8:31 PMEarnings beat and raised 2026 outlook ignite 23% surge on May 6.
Index
S&P 500
P/E
18.61
EPS (ttm)
10.42
Insider Own
2.28%
Shs Outstand
66.19M
Perf Week
27.56%
Market Cap
12.45B
Forward P/E
11.57
EPS next Y
16.76
Insider Trans
-65.69%
Shs Float
64.44M
Perf Month
29.51%
Enterprise Value
26.72B
PEG
0.59
EPS next Q
3.71
Inst Own
98.58%
Perf Quarter
36.48%
Income
756.42M
P/S
0.90
EPS this Y
34.23%
Inst Trans
-1.14%
Perf Half Y
62.86%
Sales
13.84B
P/B
-
EPS next Y
15.79%
ROA
4.37%
Perf YTD
70.65%
Book/sh
-11.41
P/C
16.62
EPS next 5Y
19.58%
ROE
635.30%
52W High
159.42 21.62%
Perf Year
35.94%
Cash/sh
11.66
P/FCF
8.34
EPS past 3/5Y
18.56% 8.29%
ROIC
6.35%
52W Low
101.00 91.96%
Perf 3Y
119.15%
EV/EBITDA
9.66
Sales past 3/5Y
5.53% 3.39%
Gross Margin
27.27%
Volatility
6.31% 3.28%
Perf 5Y
55.98%
EV/Sales
1.93
EPS Y/Y TTM
-11.49%
Oper. Margin
14.82%
ATR (14)
6.80
Perf 10Y
156.12%
Quick Ratio
1.37
Sales Y/Y TTM
6.68%
Profit Margin
5.47%
RSI (14)
82.15
Current Ratio
1.42
EPS Q/Q
43.08%
SMA20
26.52%
Beta
0.86
Debt/Eq
-
Sales Q/Q
5.96%
SMA50
27.29%
Rel Volume
3.41
Prev Close
157.04
Employees
78000
LT Debt/Eq
-
SMA200
45.46%
Avg Volume
874.40K
Price
193.88
IPO
Oct 31, 1995
Option/Short
Yes / Yes
Trades
Volume
2,940,976
Change
23.46%
Date Action Analyst Rating Change Price Target Change
May-06-26Upgrade Deutsche Bank Hold → Buy $220
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
May-06-26 06:01PM
May-05-26 04:05PM
Apr-20-26 02:06PM
Mar-31-26 08:06PM
Mar-18-26 03:00PM
11:49AM Loading…
Mar-06-26 11:49AM
Mar-05-26 12:40PM
Mar-04-26 11:30AM
10:08AM
Mar-03-26 06:56PM
Feb-27-26 04:48AM
04:03AM
03:50AM
Feb-24-26 02:00PM
09:40AM
02:53AM Loading…
02:53AM
Feb-23-26 09:40AM
Feb-20-26 09:50AM
04:09AM
Feb-19-26 09:20AM
05:30AM
04:34AM
Feb-17-26 04:53PM
Feb-13-26 10:24AM
Feb-12-26 11:03AM
10:54AM
10:41AM
09:25AM
Feb-11-26 09:15AM
Feb-10-26 12:30PM
09:32AM Loading…
09:32AM
Feb-09-26 10:38AM
08:50AM
12:31AM
Feb-05-26 09:40AM
09:40AM
Feb-04-26 07:55PM
02:54PM
10:59AM
Feb-03-26 06:03PM
04:26PM
01:18PM
12:38PM
12:25PM
11:45AM
11:16AM
11:14AM
10:23AM
09:59AM
09:40AM
08:10AM
05:54AM
12:01AM
Feb-02-26 09:55PM
08:40PM
06:38PM
05:20PM
04:20PM
04:05PM
03:00PM
Jan-31-26 10:01PM
Jan-30-26 11:56AM
Jan-29-26 11:34PM
Jan-27-26 06:00PM
Jan-21-26 06:15PM
10:00AM
Jan-19-26 12:31PM
Jan-16-26 01:56PM
04:25AM
Jan-15-26 10:34AM
Jan-14-26 11:50AM
Jan-13-26 06:00PM
Jan-07-26 06:00PM
06:00AM
Jan-02-26 09:32AM
Dec-29-25 08:53AM
01:30AM
Dec-23-25 09:02AM
Dec-22-25 06:00PM
09:14AM
Dec-19-25 09:13AM
Dec-18-25 09:07AM
Dec-15-25 09:05AM
Dec-11-25 08:00AM
Nov-28-25 11:30AM
Nov-24-25 11:49AM
Nov-14-25 04:53PM
04:16PM
Nov-13-25 10:31PM
Nov-12-25 01:11PM
Nov-10-25 06:41AM
Nov-05-25 12:38AM
Nov-04-25 08:00AM
Nov-02-25 01:07PM
Oct-30-25 07:39PM
01:59PM
01:35AM
Oct-29-25 05:25PM
05:25PM
04:05PM
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEARTY JAMES OOfficerMay 06 '26Proposed Sale169.282,184369,708May 06 04:03 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 01 '26Sale149.841,220,376182,864,67928,880,209May 05 06:52 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 06 '26Option Exercise108.938,079880,045105,833Feb 09 06:57 PM
ACKERMAN JOELCFO and TreasuerFeb 06 '26Option Exercise108.9344,0654,800,000185,705Feb 09 06:56 PM
BERKSHIRE HATHAWAY INC10% OwnerJan 29 '26Sale120.561,658,480199,939,88130,100,585Feb 02 05:30 PM
HEARTY JAMES OChief Compliance OfficerDec 04 '25Option Exercise108.935,875639,96431,913Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC10% OwnerOct 27 '25Sale135.36401,51454,347,24931,759,065Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC10% OwnerJul 31 '25Sale140.611,635,962230,024,76432,160,579Aug 04 09:00 PM
HEARTY JAMES OChief Compliance OfficerJul 23 '25Sale150.002,351352,65026,038Jul 24 08:34 PM
HEARTY JAMES OOfficerJul 23 '25Proposed Sale150.002,351352,650Jul 23 04:05 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 27 '25Sale139.45103,27414,401,48333,796,541May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 23 '25Sale137.8164,0668,828,93333,899,815May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 22 '25Sale138.9832,6604,538,98333,963,881May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 08 '25Sale147.111,145,938168,576,64733,996,541May 12 04:05 PM